We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$3.85B
AUM Growth
+$538M
Cap. Flow
+$255M
Cap. Flow %
6.63%
Top 10 Hldgs %
8.75%
Holding
1,265
New
117
Increased
828
Reduced
245
Closed
63

Sector Composition

Rank Sector Weight
1 Technology 28.89%
2 Healthcare 14.73%
3 Industrials 11.24%
4 Energy 9.78%
5 Consumer Discretionary 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RL icon
651
Ralph Lauren
RL
$24.2B
$1.14M 0.03%
9,608
-9,478
-50% -$1.14M
DOW icon
652
Dow Inc
DOW
$22.1B
$1.14M 0.03%
20,082
+2,006
+11% +$114K
NKTR icon
653
Nektar Therapeutics
NKTR
$2.53B
$1.14M 0.03%
5,610
-42
-0.7% -$9.11K
ARGX icon
654
argenx
ARGX
$54.2B
$1.14M 0.03%
3,245
-1,473
-31% -$448K
SI
655
DELISTED
Silvergate Capital Corporation
SI
$1.14M 0.03%
7,659
+123
+2% +$21K
EQC
656
DELISTED
Equity Commonwealth
EQC
$1.13M 0.03%
43,689
+583
+1% +$15.2K
MANT
657
DELISTED
Mantech International Corp
MANT
$1.13M 0.03%
15,524
+535
+4% +$40.8K
WH icon
658
Wyndham Hotels & Resorts
WH
$5.29B
$1.13M 0.03%
12,603
+720
+6% +$60.2K
ITOS
659
DELISTED
iTeos Therapeutics
ITOS
$1.13M 0.03%
+24,153
New +$804K
BAX icon
660
Baxter International
BAX
$14.4B
$1.12M 0.03%
13,072
+1,172
+10% +$94.3K
SHLX
661
DELISTED
Shell Midstream Partners, L.P.
SHLX
$1.12M 0.03%
97,285
+5,360
+6% +$63.2K
AKAM icon
662
Akamai
AKAM
$16.9B
$1.12M 0.03%
9,561
+1,177
+14% +$129K
RPD icon
663
Rapid7
RPD
$776M
$1.12M 0.03%
9,507
+770
+9% +$95K
CRSP icon
664
CRISPR Therapeutics
CRSP
$5.17B
$1.12M 0.03%
14,734
+1,880
+15% +$164K
HRB icon
665
H&R Block
HRB
$5.82B
$1.11M 0.03%
47,113
+9,570
+25% +$232K
CHH icon
666
Choice Hotels
CHH
$4.62B
$1.1M 0.03%
7,067
+391
+6% +$56.1K
ADEA icon
667
Adeia
ADEA
$3.07B
$1.1M 0.03%
219,886
+8,308
+4% +$41.4K
MAS icon
668
Masco
MAS
$14.7B
$1.1M 0.03%
15,659
+1,399
+10% +$90.5K
GPN icon
669
Global Payments
GPN
$22.8B
$1.09M 0.03%
8,083
+1,136
+16% +$157K
BCYC
670
Bicycle Therapeutics
BCYC
$288M
$1.09M 0.03%
+17,933
New +$989K
FAST icon
671
Fastenal
FAST
$59.8B
$1.09M 0.03%
33,980
-834
-2% -$24.6K
GM icon
672
General Motors
GM
$77.2B
$1.08M 0.03%
18,488
+8,025
+77% +$469K
FATE icon
673
Fate Therapeutics
FATE
$322M
$1.08M 0.03%
18,506
+2,023
+12% +$115K
PBCT
674
DELISTED
People's United Financial Inc
PBCT
$1.07M 0.03%
60,317
+7,465
+14% +$133K
ESTC icon
675
Elastic
ESTC
$7.93B
$1.07M 0.03%
8,719
+395
+5% +$59.7K

Similar funds

Vident Investment Advisory's Q4 2021 Portfolio in Review

As of Q4 2021, Vident Investment Advisory held 1,265 positions worth $3.85B, up 16% from $3.31B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Vident Investment Advisory deployed $255M of net new capital in Q4 2021, opening 117 new positions and adding to 828 existing holdings. Its largest new stake was Vicarious Surgical: 35,777 shares worth $11.4M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was iRhythm Holdings, an estimated $27.4M trimmed.

  • Vident Investment Advisory's largest Q4 2021 buy was Vicarious Surgical: 35,777 shares worth $11.4M.
  • Vident Investment Advisory added most to 3D Systems Corp in Q4 2021, an estimated $9.25M increase.
  • Vident Investment Advisory's biggest Q4 2021 reduction was iRhythm Holdings, cutting an estimated $27.4M.
  • Vident Investment Advisory fully exited Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) in Q4 2021, selling an estimated $27.4M.
  • Vident Investment Advisory's ten largest holdings make up 8.7% of its $3.85B portfolio in Q4 2021.
  • Vident Investment Advisory opened 117 new positions and closed 63 in Q4 2021.
  • Vident Investment Advisory's portfolio value rose 16% quarter-over-quarter to $3.85B.

Based on Vident Investment Advisory's 13F filing for Q4 2021, filed 14 Feb 2022.